The Antibiotic Paradox: Why Companies Can’t Afford to Create Life-Saving Drugs
4th October 2020
They don’t come out and say so, but the finger pretty plainly points to the regulatory burden imposed by the FDA and similar agencies.
And then when they do come up with a successful product, the pressure starts to sell it for less than it costs to make, or even to give it away for free.